跳至主要内容
临床试验/KCT0007229
KCT0007229尚未招募未知

Add-on effect and safety of pharmacopuncture therapy in the treatment of patients with lumbar spinal stenosis: a pragmatic assessor-blinded, randomized, controlled pilot trial

Korea Institute of Oriental Medicine0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
40?(Year) 至 80?(Year)(—)
性别
All

入选标准

  • 1. Diagnosed with lumbar spinal stenosis by CT or MRI.
  • - If there is no existing image data or if re-examination is necessary, L-spine CT scan will be performed
  • 2. Pain or discomfort in the lower extremities/buttocks = VAS 40mm
  • 3. Those who have clinical features of spinal stenosis, such as neurogenic claudication or changes in symptoms due to position
  • 4. Those who are finally diagnosed with lumbar spinal stenosis as a result of a comprehensive physical examination, medical history examination, and imaging examination
  • 5. Those who voluntarily decide to participate after hearing the explanation of the research purpose and process and consent in writing

排除标准

  • 1. Those who are diagnosed with congenital or developmental spinal stenosis
  • 2. Those who have serious defects due to spinal canal problems such as spinal segment muscle atrophy, gait disorder, and Cauda equina syndrome
  • 3. Those who are moderate to severe spinal malalignment and spinal instability due to spondylolisthesis, spondylolysis, thoracic and lumbar fractures, etc.
  • 4. Those who are diagnosed with other spinal diseases such as vertebral body tumors, spinal infections, ankylosing spondylosis, etc.
  • 5. History of spinal surgery such as spinal fusion or laminectomy
  • 6. Those who have factors that may affect hemostasis, such as taking anticoagulants and antiplatelet drugs, and bleeding disorders
  • 7. History of acupuncture hypersensitivity, metal allergy, severe atopic dermatitis, keloid skin, and other skin hypersensitivity
  • 8. Those with moderate to severe chronic kidney disease (Chronic Kidney Disease stage = 4), uncontrolled diabetes mellitus, or severe cardiovascular disease
  • 9. Those who have a significant neuropsychiatric history or who are currently mentally or cognitively unstable
  • 10. History of alcoholism or drug abuse
  • 11. Those who have a serious underlying disease who is receiving active treatment for it
  • 12. Pregnant woman, lactating woman, or woman in childbearing years who plans on being pregnant
  • 13. Those who can not write informed consent/data by themselves or under the supervision of a guardian/researcher
  • 14. Those who are difficult to participate in the trial according to investigator's decision

研究者

相似试验

Add-on effect and safety of pharmacopuncture ... | 临床试验